Find information about GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for health care professionals. Please see Important Safety Information on this website.

GARDASIL 9 is indicated in males 9 through 45 years of age for the prevention of anal, oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58; anal precancerous or dysplastic lesions caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58; and genital warts caused by HPV Types 6 and 11.

RAHWAY, N.J., Jan. 28, 2025 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today reaffirmed its commitment to defending the safety and efficacy of its HPV vaccines. Merck is a defendant in product liability lawsuits in the United States involving GARDASIL® (Human Papillomavirus Quadrivalent [Types 6, 11, 16 and […]

Dec 11, 2014 · GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine . Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved GARDASIL ® 9 (Human Papillomavirus 9-valent Vaccine,

GARDASIL 9 does not treat HPV infection, cancer, or genital warts. GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots. For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule.

Jan 27, 2025 · Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical...

Jun 12, 2020 · GARDASIL ® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Now Approved for the Prevention of HPV-Related Cervical, Vaginal, Vulvar, Anal, Oropharyngeal and Other Head and Neck Cancers

Gardasil is an HPV vaccine for use in the prevention of certain strains of human papillomavirus (HPV). [10] [7] [8] [9] [11] It was developed by Merck & Co. [12] High-risk human papilloma virus (hr-HPV) genital infection is the most common sexually transmitted infection among women. [13]

Jan 27, 2025 · Jurors will weigh whether Merck withheld side-effect reports and launched misleading marketing campaigns to turn the drug into a blockbuster product.

The low end of Merck's revenue guidance assumes no further shipments in China, and less than $1 billion in sales at the high end. Merck CEO Robert Davis said on an earnings call that Gardasil ...